COMBINATION OF CELLULAR ASSAYS WITH METABOLOMICS REVEALED MECHANISTIC INSIGHTS ON DOSE-RESPONSE RELATIONSHIP OF 3- NITROBENZANTHRONE IN HUMAN UROTHELIAL CANCER CELLS